Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Primary
Care Companionfor CNS Disorders

Free access
Suicide

Letter to the Editor October 15, 2008

Low Cholesterol, Delinquency, and Suicidality

Luca Mascitelli, M.D.; Francesca Pezzetta, M.D.; Mark R. Goldstein, M.D.

Prim Care Companion J Clin Psychiatry 2008;10(5):413-414

Article Abstract

Letter to the Editor

Low Cholesterol, Delinquincy, and Suicidality

About the Authors

  • Luca Mascitelli, M.D.
    View full profile
  • Francesca Pezzetta, M.D.
    View full profile
  • Mark R. Goldstein, M.D.
    View full profile
Download Free PDF

This PDF is free for all visitors!

Related News Articles

Weekly Mind Reader: Rage Isn’t Just Anger Suicide Risk Skyrockets After Involuntary Psychiatric Discharge Weekly Mind Reader: Retired Veterans Endangered?
Announcement: The Journal of Clinical Psychiatry launches a new podcast. Click to learn more.

Related JCP Articles

Psychiatric Hospitalization and Suicide Attempts in Healthcare Professionals Precision Medicine for Suicide Prevention: It’s Time to Take the Next Step Reframing the Discussion on Finasteride and Neuropsychiatric Safety

Related PCC Articles

Comorbidities Obscure Autism Diagnosis Serious Suicide Attempt Management Suicide-Specific Cognitions in US Military Veterans
Figure: Journal cover summarizes articles on suicide impact, gender-affirming care, drone trauma, veteran toxins, and prenatal substance use.

Vol 27 • 2025 • Number 6

Read the Current Issue

Original Research

Impact of Patient Suicide on Mental Health Professionals

Review Article

Gender-Affirming Surgery, Gender Dysphoria, and QOL

Rounds in the General Hospital

Psychological Sequelae of Drone Attacks

Rounds in the General Hospital

Sequelae of Toxic Exposures in Veterans

Rounds in the General Hospital

Talking to Pregnant Patients About Substance Use

Case Report

Tetrabenazine-Induced Suicidality

View current Issue

Related Articles

JCP
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
Letter to the Editor

Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
Bénédicte Nobile, Philippe Courtet
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini, Pierre A. Geoffroy, Jean Arthur Micoulaud-Franchi, et al
JCP
Possible Suicidal Risk With Daridorexant
Letter to the Editor

Possible Suicidal Risk With Daridorexant

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...
Bénédicte Nobile, Emilie Olié, Philippe Courtet

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • THREADS
  • BLUESKY
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2026 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap